{
     "PMID": "9015823",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19970417",
     "LR": "20051116",
     "IS": "0301-0082 (Print) 0301-0082 (Linking)",
     "VI": "50",
     "IP": "5-6",
     "DP": "1996 Dec",
     "TI": "Implication of ATP receptors in brain functions.",
     "PG": "483-92",
     "AB": "The possible implication of P2-purinoceptors in brain functions is reviewed. Involvement of P2-purinoceptors in memory and learning (Section 2) is suggested by ATP release from hippocampal slices [Wieraszko, A., Goldsmith, G. and Seyfried, T. N. (1989) Brain Res. 485, 244-250], induction of fast synaptic currents in cultured hippocampal neurons [Inoue, K., Nakazawa, K., Fujimori, W. and Takanaka, A. (1992a) Neurosci. Lett. 134, 294-299] and long-lasting enhancement of the population spikes [Wieraszko, A. and Seyfried, T. N. (1989) Brain Res. 491, 356-359; Nishimura, S., Mohri, M., Okada, Y. and Mori, M. (1990) Brain Res. 525, 165-169; Fujii, S., Kato, H., Furuse, H., Ito, K., Osada, H., Hamaguchi, T. and Kuroda, Y. (1995) Neurosci, Lett. 187, 130-132], as well as ATP release on glutamate stimulation to evoke an increase in intracellular Ca2+ in hippocampal cells [Inoue, K., Koizum, S. and Nakazawa, K. (1995) NeuroReport 6, 437-440]. Moreover, mRNAs for certain types of P2x-purinoceptors are present in the hippocampus [Collo, G., North, R. A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A. and Buell, G. (1996) J. Neurosci. 16, 2495-2507]. It is likely, therefore, that ATP may be involved in modulation of synaptic efficiency in the hippocampus. The implication of ATP in schizophrenia is suggested by the fact that antipsychotic drugs inhibit ATP-evoked responses in PC12 cells [Koizumi, S., Ikeda, M., Nakazawa, K., Inoue, K., Ito, K. and Inoue, K. (1995b) Biochem. Biophys. Res. Commun. 210, 624-630] without blocking the action of dopamine D2 receptors. Involvement of P2-purinoceptors in Sections 4 (\"Pain and cognition\") and 5 (\"Central regulation of the autonomic system\") are also discussed.",
     "FAU": [
          "Inoue, K",
          "Koizumi, S",
          "Ueno, S"
     ],
     "AU": [
          "Inoue K",
          "Koizumi S",
          "Ueno S"
     ],
     "AD": "Division of Pharmacology, National Institute of Health Sciences, Tokyo, Japan. inoue@nihs.go.jp",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Review"
     ],
     "PL": "England",
     "TA": "Prog Neurobiol",
     "JT": "Progress in neurobiology",
     "JID": "0370121",
     "RN": [
          "0 (Receptors, Purinergic P2)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain/*physiology/physiopathology",
          "Humans",
          "Receptors, Purinergic P2/*physiology"
     ],
     "RF": "73",
     "EDAT": "1996/12/01 00:00",
     "MHDA": "1996/12/01 00:01",
     "CRDT": [
          "1996/12/01 00:00"
     ],
     "PHST": [
          "1996/12/01 00:00 [pubmed]",
          "1996/12/01 00:01 [medline]",
          "1996/12/01 00:00 [entrez]"
     ],
     "AID": [
          "S0301-0082(96)00037-8 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Prog Neurobiol. 1996 Dec;50(5-6):483-92.",
     "term": "hippocampus"
}